{"transactions":[{"id":746005,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-06-09T01:19:45.000Z","date":"2026-06-05","kind":"sale","planned":true,"acquired":false,"shares":1322,"price":53.14,"value":70251.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted by the reporting person on August 17, 2025, solely to satisfy income tax obligations related to the vesting of RSUs granted on June 5, 2025."}],"balance_after":24896,"source":{"system":"sec-edgar","filing":"0001193125-26-262672","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000119312526262672/ownership.xml","form_type":"4"}},{"id":751360,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-04T01:04:59.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":1593,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each RSU represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each RSU represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders."}],"balance_after":1593,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":1593},"source":{"system":"sec-edgar","filing":"0001193125-26-256126","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000119312526256126/ownership.xml","form_type":"4"}},{"id":751359,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2026-06-04T01:04:59.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":10507,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders."}],"balance_after":10507,"derivative":{"exercise_price":53.46,"expiration_date":"2036-06-02","underlying":"Common Shares","underlying_shares":10507},"source":{"system":"sec-edgar","filing":"0001193125-26-256126","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000119312526256126/ownership.xml","form_type":"4"}},{"id":751358,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-04T01:04:59.000Z","date":"2026-06-01","kind":"exercise","planned":false,"acquired":false,"shares":2645,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents Common Shares earned and vested under a restricted share unit (\"RSU\") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents Common Shares earned and vested under a restricted share unit (\"RSU\") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents Common Shares earned and vested under a restricted share unit (\"RSU\") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders."}],"balance_after":0,"derivative":{"underlying":"Common Shares","underlying_shares":2645},"source":{"system":"sec-edgar","filing":"0001193125-26-256126","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000119312526256126/ownership.xml","form_type":"4"}},{"id":751357,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-06-04T01:04:59.000Z","date":"2026-06-01","kind":"exercise","planned":false,"acquired":true,"shares":2645,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Common Shares earned and vested under a restricted share unit (\"RSU\") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Common Shares earned and vested under a restricted share unit (\"RSU\") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders."}],"balance_after":26218,"source":{"system":"sec-edgar","filing":"0001193125-26-256126","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000119312526256126/ownership.xml","form_type":"4"}},{"id":1119414,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2025-06-06T22:00:25.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":2645,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each restricted share unit represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 4, 2026 or (ii) the day before the date of the issuer's 2026 annual meeting of shareholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted share unit represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 4, 2026 or (ii) the day before the date of the issuer's 2026 annual meeting of shareholders."}],"balance_after":2645,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":2645},"source":{"system":"sec-edgar","filing":"0000950170-25-083329","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000095017025083329/ownership.xml","form_type":"4"}},{"id":1119413,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2025-06-06T22:00:25.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":17012,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting 100% on the earlier of (i) June 4, 2026 or (ii) the day before the date of the issuer's 2026 annual meeting of shareholders."}],"balance_after":17012,"derivative":{"exercise_price":30.73,"expiration_date":"2035-06-04","underlying":"Common Shares","underlying_shares":17012},"source":{"system":"sec-edgar","filing":"0000950170-25-083329","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000095017025083329/ownership.xml","form_type":"4"}},{"id":1354005,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-11-23T00:48:02.000Z","date":"2024-11-22","kind":"exercise","planned":false,"acquired":false,"shares":3086,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":13.48,"expiration_date":"2025-05-03","underlying":"Common Shares","underlying_shares":3086},"source":{"system":"sec-edgar","filing":"0000950170-24-130378","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000095017024130378/ownership.xml","form_type":"4"}},{"id":1354004,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-11-23T00:48:02.000Z","date":"2024-11-22","kind":"exercise","planned":false,"acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":7.38,"expiration_date":"2026-06-01","underlying":"Common Shares","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0000950170-24-130378","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000095017024130378/ownership.xml","form_type":"4"}},{"id":1354003,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-11-23T00:48:02.000Z","date":"2024-11-22","kind":"sale","planned":false,"acquired":false,"shares":2040,"price":41.05,"value":83742.0,"ownership":{"direct":true},"balance_after":23573,"source":{"system":"sec-edgar","filing":"0000950170-24-130378","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000095017024130378/ownership.xml","form_type":"4"}},{"id":1354002,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-11-23T00:48:02.000Z","date":"2024-11-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":1046,"price":39.8,"value":41630.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the closing price of the Company's common shares on November 21, 2024 for purposes of net settlement calculations."}],"balance_after":25613,"source":{"system":"sec-edgar","filing":"0000950170-24-130378","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000095017024130378/ownership.xml","form_type":"4"}},{"id":1354001,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-11-23T00:48:02.000Z","date":"2024-11-22","kind":"exercise","planned":false,"acquired":true,"shares":3086,"price":13.48,"value":41599.28,"ownership":{"direct":true},"balance_after":26659,"source":{"system":"sec-edgar","filing":"0000950170-24-130378","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000095017024130378/ownership.xml","form_type":"4"}},{"id":1354000,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-11-23T00:48:02.000Z","date":"2024-11-22","kind":"sale","planned":false,"acquired":false,"shares":2851,"price":41.11,"value":117204.61,"ownership":{"direct":true},"balance_after":23573,"source":{"system":"sec-edgar","filing":"0000950170-24-130378","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000095017024130378/ownership.xml","form_type":"4"}},{"id":1353999,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-11-23T00:48:02.000Z","date":"2024-11-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":649,"price":39.8,"value":25830.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the closing price of the Company's common shares on November 21, 2024 for purposes of net settlement calculations."}],"balance_after":26424,"source":{"system":"sec-edgar","filing":"0000950170-24-130378","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000095017024130378/ownership.xml","form_type":"4"}},{"id":1353998,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-11-23T00:48:02.000Z","date":"2024-11-22","kind":"exercise","planned":false,"acquired":true,"shares":3500,"price":7.38,"value":25830.0,"ownership":{"direct":true},"balance_after":27073,"source":{"system":"sec-edgar","filing":"0000950170-24-130378","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000095017024130378/ownership.xml","form_type":"4"}},{"id":1489761,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-05T21:43:06.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":15542,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting 100% on the earlier of (i) June 4, 2025 or (ii) the day before the date of the issuer's 2025 annual meeting of shareholders."}],"balance_after":15542,"derivative":{"exercise_price":38.16,"expiration_date":"2034-06-04","underlying":"Common Shares","underlying_shares":15542},"source":{"system":"sec-edgar","filing":"0000950170-24-069468","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000095017024069468/ownership.xml","form_type":"4"}},{"id":1709041,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-12-16T02:50:05.000Z","date":"2023-12-14","kind":"sale","planned":false,"acquired":false,"shares":7598,"price":41.05,"value":311897.9,"ownership":{"direct":false,"nature":"See Note"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the terms of a Lock-Up Agreement executed by the Reporting Person in favor of the underwriters of the Company's follow-on public offering in November 2023, the Reporting Person is permitted to transfer up to 22,000 common shares beneficially owned prior to November 29, 2023 or received upon the exercise of an option to purchase common shares during the lock-up period."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $41.00 to $41.06, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"By Gary & Karen Barbara Patou TTEE Patou Family Trust FBO Gary Patou Karen Barbara Patou."}],"balance_after":4902,"source":{"system":"sec-edgar","filing":"0000950170-23-070912","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000095017023070912/ownership.xml","form_type":"4/A","original_submission_date":"2023-12-15"}},{"id":1709040,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-15T22:38:20.000Z","date":"2023-12-13","kind":"exercise","planned":false,"acquired":false,"shares":5144,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":9,"exercise_date":"2017-11-04","expiration_date":"2024-11-03","underlying":"Common Shares","underlying_shares":5144},"source":{"system":"sec-edgar","filing":"0000950170-23-070841","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000095017023070841/ownership.xml","form_type":"4"}},{"id":1709039,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-15T22:38:20.000Z","date":"2023-12-13","kind":"exercise","planned":false,"acquired":false,"shares":2800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The exercise price was converted to U.S. dollars from $10.78 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."}],"balance_after":0,"derivative":{"exercise_price":9.85,"exercise_date":"2016-12-31","expiration_date":"2024-01-13","underlying":"Common Shares","underlying_shares":2800},"source":{"system":"sec-edgar","filing":"0000950170-23-070841","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000095017023070841/ownership.xml","form_type":"4"}},{"id":1709038,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-15T22:38:20.000Z","date":"2023-12-13","kind":"exercise","planned":false,"acquired":false,"shares":6378,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The exercise price was converted to U.S. dollars from $10.78 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."}],"balance_after":0,"derivative":{"exercise_price":9.85,"exercise_date":"2016-12-31","expiration_date":"2024-01-13","underlying":"Common Shares","underlying_shares":6378},"source":{"system":"sec-edgar","filing":"0000950170-23-070841","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000095017023070841/ownership.xml","form_type":"4"}},{"id":1709037,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-12-15T22:38:20.000Z","date":"2023-12-13","kind":"sale","planned":false,"acquired":false,"shares":7598,"price":41.05,"value":311897.9,"ownership":{"direct":false,"nature":"See Note"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the terms of a Lock-Up Agreement executed by the Reporting Person in favor of the underwriters of the Company's follow-on public offering in November 2023, the Reporting Person is permitted to transfer up to 22,000 common shares beneficially owned prior to November 29, 2023 or received upon the exercise of an option to purchase common shares during the lock-up period."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $41.00 to $41.06, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"By Gary & Karen Barbara Patou TTEE Patou Family Trust FBO Gary Patou Karen Barbara Patou."}],"balance_after":4902,"source":{"system":"sec-edgar","filing":"0000950170-23-070841","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000095017023070841/ownership.xml","form_type":"4"}},{"id":1709036,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-12-15T22:38:20.000Z","date":"2023-12-13","kind":"sale","planned":false,"acquired":false,"shares":3977,"price":39.84,"value":158443.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the terms of a Lock-Up Agreement executed by the Reporting Person in favor of the underwriters of the Company's follow-on public offering in November 2023, the Reporting Person is permitted to transfer up to 22,000 common shares beneficially owned prior to November 29, 2023 or received upon the exercise of an option to purchase common shares during the lock-up period."}],"balance_after":23573,"source":{"system":"sec-edgar","filing":"0000950170-23-070841","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000095017023070841/ownership.xml","form_type":"4"}},{"id":1709035,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-12-15T22:38:20.000Z","date":"2023-12-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":1167,"price":39.68,"value":46306.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the terms of a Lock-Up Agreement executed by the Reporting Person in favor of the underwriters of the Company's follow-on public offering in November 2023, the Reporting Person is permitted to transfer up to 22,000 common shares beneficially owned prior to November 29, 2023 or received upon the exercise of an option to purchase common shares during the lock-up period."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the closing price of the Company's common shares in U.S. dollars on December 12, 2023, which was converted to a Canadian dollar amount for purposes of net settlement calculations."}],"balance_after":27550,"source":{"system":"sec-edgar","filing":"0000950170-23-070841","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000095017023070841/ownership.xml","form_type":"4"}},{"id":1709034,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-12-15T22:38:20.000Z","date":"2023-12-13","kind":"exercise","planned":false,"acquired":true,"shares":5144,"price":9,"value":46296.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the terms of a Lock-Up Agreement executed by the Reporting Person in favor of the underwriters of the Company's follow-on public offering in November 2023, the Reporting Person is permitted to transfer up to 22,000 common shares beneficially owned prior to November 29, 2023 or received upon the exercise of an option to purchase common shares during the lock-up period."}],"balance_after":28717,"source":{"system":"sec-edgar","filing":"0000950170-23-070841","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000095017023070841/ownership.xml","form_type":"4"}},{"id":1709033,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-12-15T22:38:20.000Z","date":"2023-12-13","kind":"sale","planned":false,"acquired":false,"shares":2303,"price":39.1,"value":90047.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the terms of a Lock-Up Agreement executed by the Reporting Person in favor of the underwriters of the Company's follow-on public offering in November 2023, the Reporting Person is permitted to transfer up to 22,000 common shares beneficially owned prior to November 29, 2023 or received upon the exercise of an option to purchase common shares during the lock-up period."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $39.04 to $39.16, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":23573,"source":{"system":"sec-edgar","filing":"0000950170-23-070841","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000095017023070841/ownership.xml","form_type":"4"}},{"id":1709032,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-12-15T22:38:20.000Z","date":"2023-12-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":577,"price":39.68,"value":22895.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the terms of a Lock-Up Agreement executed by the Reporting Person in favor of the underwriters of the Company's follow-on public offering in November 2023, the Reporting Person is permitted to transfer up to 22,000 common shares beneficially owned prior to November 29, 2023 or received upon the exercise of an option to purchase common shares during the lock-up period."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the closing price of the Company's common shares in U.S. dollars on December 12, 2023, which was converted to a Canadian dollar amount for purposes of net settlement calculations."}],"balance_after":25876,"source":{"system":"sec-edgar","filing":"0000950170-23-070841","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000095017023070841/ownership.xml","form_type":"4"}},{"id":1709031,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-12-15T22:38:20.000Z","date":"2023-12-13","kind":"exercise","planned":false,"acquired":true,"shares":2880,"price":9.85,"value":28368.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the terms of a Lock-Up Agreement executed by the Reporting Person in favor of the underwriters of the Company's follow-on public offering in November 2023, the Reporting Person is permitted to transfer up to 22,000 common shares beneficially owned prior to November 29, 2023 or received upon the exercise of an option to purchase common shares during the lock-up period."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The exercise price was converted to U.S. dollars from $10.78 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."}],"balance_after":26453,"source":{"system":"sec-edgar","filing":"0000950170-23-070841","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000095017023070841/ownership.xml","form_type":"4"}},{"id":1709030,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-12-15T22:38:20.000Z","date":"2023-12-13","kind":"sale","planned":false,"acquired":false,"shares":5100,"price":38.94,"value":198594.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the terms of a Lock-Up Agreement executed by the Reporting Person in favor of the underwriters of the Company's follow-on public offering in November 2023, the Reporting Person is permitted to transfer up to 22,000 common shares beneficially owned prior to November 29, 2023 or received upon the exercise of an option to purchase common shares during the lock-up period."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $38.81 to $39.13, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":23573,"source":{"system":"sec-edgar","filing":"0000950170-23-070841","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000095017023070841/ownership.xml","form_type":"4"}},{"id":1709029,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-12-15T22:38:20.000Z","date":"2023-12-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":1278,"price":39.68,"value":50711.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the terms of a Lock-Up Agreement executed by the Reporting Person in favor of the underwriters of the Company's follow-on public offering in November 2023, the Reporting Person is permitted to transfer up to 22,000 common shares beneficially owned prior to November 29, 2023 or received upon the exercise of an option to purchase common shares during the lock-up period."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the closing price of the Company's common shares in U.S. dollars on December 12, 2023, which was converted to a Canadian dollar amount for purposes of net settlement calculations."}],"balance_after":28673,"source":{"system":"sec-edgar","filing":"0000950170-23-070841","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000095017023070841/ownership.xml","form_type":"4"}},{"id":1709028,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-12-15T22:38:20.000Z","date":"2023-12-13","kind":"exercise","planned":false,"acquired":true,"shares":6378,"price":9.85,"value":62823.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the terms of a Lock-Up Agreement executed by the Reporting Person in favor of the underwriters of the Company's follow-on public offering in November 2023, the Reporting Person is permitted to transfer up to 22,000 common shares beneficially owned prior to November 29, 2023 or received upon the exercise of an option to purchase common shares during the lock-up period."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The exercise price was converted to U.S. dollars from $10.78 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."}],"balance_after":29951,"source":{"system":"sec-edgar","filing":"0000950170-23-070841","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000095017023070841/ownership.xml","form_type":"4"}},{"id":1869389,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-02T21:27:14.000Z","date":"2023-06-02","kind":"grant","planned":false,"acquired":true,"shares":18475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting 100% on the earlier of (i) June 1, 2024 or (ii) the day immediately preceding the day of the following year's annual meeting."}],"balance_after":18475,"derivative":{"exercise_price":38.96,"expiration_date":"2033-06-01","underlying":"Common Shares","underlying_shares":18475},"source":{"system":"sec-edgar","filing":"0000950170-23-026190","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000095017023026190/ownership.xml","form_type":"4"}},{"id":2103272,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-11-29T01:41:46.000Z","date":"2022-11-25","kind":"exercise","acquired":false,"shares":2057,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The exercise price was converted to U.S. dollars from $2.67 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares subject to the option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":2.68,"expiration_date":"2022-12-31","underlying":"Common Shares","underlying_shares":2057},"source":{"system":"sec-edgar","filing":"0001209191-22-058916","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000120919122058916/doc4.xml","form_type":"4"}},{"id":2103271,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-11-29T01:41:46.000Z","date":"2022-11-25","kind":"sale","acquired":false,"shares":1937,"price":34.7911,"value":67390.3607,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $34.76 to $34.90, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":23573,"source":{"system":"sec-edgar","filing":"0001209191-22-058916","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000120919122058916/doc4.xml","form_type":"4"}},{"id":2103270,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-11-29T01:41:46.000Z","date":"2022-11-25","kind":"tax_withholding","acquired":false,"shares":120,"price":34.37,"value":4124.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the closing price of the Company's common shares on November 23, 2022 for purposes of net settlement calculations."}],"balance_after":25510,"source":{"system":"sec-edgar","filing":"0001209191-22-058916","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000120919122058916/doc4.xml","form_type":"4"}},{"id":2103269,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-11-29T01:41:46.000Z","date":"2022-11-25","kind":"exercise","acquired":true,"shares":2057,"price":2.68,"value":5512.76,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The exercise price was converted to U.S. dollars from $2.67 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."}],"balance_after":25630,"source":{"system":"sec-edgar","filing":"0001209191-22-058916","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000120919122058916/doc4.xml","form_type":"4"}},{"id":2103268,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-11-29T01:41:46.000Z","date":"2022-11-23","kind":"sale","acquired":false,"shares":2057,"price":34.3265,"value":70609.6105,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $34.24 to $34.36, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":23573,"source":{"system":"sec-edgar","filing":"0001209191-22-058916","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000120919122058916/doc4.xml","form_type":"4"}},{"id":2219286,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-29T21:40:06.000Z","date":"2022-06-28","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the common shares subject to the option will vest on the earlier of (i) the first anniversary of grant date and (ii) the day immediately preceding the day of the Issuer's next annual general meeting of shareholders."}],"balance_after":18000,"derivative":{"exercise_price":30.11,"expiration_date":"2032-06-27","underlying":"Common Shares","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001209191-22-039833","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000120919122039833/doc4.xml","form_type":"4"}},{"id":2477026,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-10T21:20:15.000Z","date":"2021-12-08","kind":"exercise","acquired":false,"shares":2057,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/3 of the shares subject to the Option vested on January 1, 2013 (the \"2012 Vesting Commencement Date\") and thereafter the remaining 2/3 of the shares subject to the Option vest each monthly anniversary of the 2012 Vesting Commencement Date over the following 2 years."}],"balance_after":0,"derivative":{"exercise_price":3.67,"expiration_date":"2021-12-31","underlying":"Common Shares","underlying_shares":2057},"source":{"system":"sec-edgar","filing":"0001209191-21-069018","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000120919121069018/doc4.xml","form_type":"4"}},{"id":2477025,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2021-12-10T21:20:15.000Z","date":"2021-12-08","kind":"exercise","acquired":true,"shares":2057,"price":3.67,"value":7549.19,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."}],"balance_after":25630,"source":{"system":"sec-edgar","filing":"0001209191-21-069018","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000120919121069018/doc4.xml","form_type":"4"}},{"id":2680734,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-04T23:20:26.000Z","date":"2021-06-03","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third of the total shares subject to the Option shall vest on the one year anniversary of the grant date, one-third of the total shares subject to\nthe Option shall vest on the two year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the three year\nanniversary of the grant date."}],"balance_after":10000,"derivative":{"exercise_price":18.56,"expiration_date":"2031-06-02","underlying":"Common Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-038431","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000120919121038431/doc4.xml","form_type":"4"}},{"id":2680733,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2021-06-04T23:20:26.000Z","date":"2021-03-17","kind":"other","acquired":true,"shares":100,"price":19.49,"value":1949.0,"ownership":{"direct":false,"nature":"See Note"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares acquired by the reporting person's son sharing the reporting person's household on the date of acquisition. Subsequent to the acquisition of the reported shares, the reporting person's son no longer shares a household with the reporting person and the reporting person no longer has a reportable beneficial interest in such shares. Subsequent ownership reports filed by the reporting person will not report these shares."}],"balance_after":100,"source":{"system":"sec-edgar","filing":"0001209191-21-038431","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000120919121038431/doc4.xml","form_type":"4"}},{"id":2998013,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-29T20:20:05.000Z","date":"2020-10-28","kind":"exercise","acquired":false,"shares":2057,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option fully vested on December 31, 2013. The date the options became fully vested was incorrectly reflected on the Reporting Person's Form 3."}],"balance_after":0,"derivative":{"exercise_price":3.76,"expiration_date":"2020-12-31","underlying":"Common Shares","underlying_shares":2057},"source":{"system":"sec-edgar","filing":"0001209191-20-056222","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000120919120056222/doc4.xml","form_type":"4"}},{"id":2998012,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2020-10-29T20:20:05.000Z","date":"2020-10-28","kind":"exercise","acquired":true,"shares":2057,"price":3.76,"value":7734.32,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."}],"balance_after":23573,"source":{"system":"sec-edgar","filing":"0001209191-20-056222","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000120919120056222/doc4.xml","form_type":"4"}},{"id":3126694,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-02T21:32:35.000Z","date":"2020-06-01","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the total shares subject to the Option shall vest on the one year anniversary of the grant date, one-third of the total shares subject to\nthe Option shall vest on the two year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the three year\nanniversary of the grant date."}],"balance_after":10000,"derivative":{"exercise_price":13.11,"expiration_date":"2030-05-31","underlying":"Common Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-20-033653","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000120919120033653/doc4.xml","form_type":"4"}},{"id":3349641,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-12-06T22:12:52.000Z","date":"2019-12-04","kind":"exercise","acquired":false,"shares":2057,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option fully vested on December 31, 2012. The date the options became fully vested was incorrectly reflected on the Reporting Person's Form 3."}],"balance_after":0,"derivative":{"exercise_price":3.56,"expiration_date":"2019-12-31","underlying":"Common Shares","underlying_shares":2057},"source":{"system":"sec-edgar","filing":"0001209191-19-059515","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000120919119059515/doc4.xml","form_type":"4"}},{"id":3349640,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2019-12-06T22:12:52.000Z","date":"2019-12-04","kind":"exercise","acquired":true,"shares":2057,"price":3.56,"value":7322.92,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise."}],"balance_after":21516,"source":{"system":"sec-edgar","filing":"0001209191-19-059515","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000120919119059515/doc4.xml","form_type":"4"}},{"id":3410690,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-18T22:51:48.000Z","date":"2019-09-16","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the total shares subject to the Option shall vest on the one year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the two year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the three year anniversary of the grant date."}],"balance_after":15000,"derivative":{"exercise_price":9.44,"expiration_date":"2029-09-15","underlying":"Common Shares","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-19-050146","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000120919119050146/doc4.xml","form_type":"4"}},{"id":3726546,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-12-18T21:06:10.000Z","date":"2018-12-14","kind":"exercise","acquired":false,"shares":2057,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"By Gary & Karen Barbara Patou TTEE Patou Family Trust FBO Gary Patou Karen Barbara Patou."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option fully vested on December 31, 2011."}],"balance_after":0,"derivative":{"exercise_price":3.07,"expiration_date":"2018-12-31","underlying":"Common Shares","underlying_shares":2057},"source":{"system":"sec-edgar","filing":"0001171843-18-008471","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000117184318008471/ownership.xml","form_type":"4"}},{"id":3726545,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2018-12-18T21:06:10.000Z","date":"2018-12-14","kind":"exercise","acquired":true,"shares":2057,"price":3.07,"value":6314.99,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The exercise price was converted to U.S. dollars from $3.74 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the day of exercise."}],"balance_after":19459,"source":{"system":"sec-edgar","filing":"0001171843-18-008471","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000117184318008471/ownership.xml","form_type":"4"}},{"id":3892289,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-15T23:32:06.000Z","date":"2018-06-14","kind":"exercise","acquired":false,"shares":8230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted to U.S. dollars from $3.74 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the day of exercise."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option fully vested on May 31, 2011."}],"balance_after":0,"derivative":{"exercise_price":3.7,"expiration_date":"2018-06-26","underlying":"Common Shares","underlying_shares":8230},"source":{"system":"sec-edgar","filing":"0001171843-18-004695","document":"formfour.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000117184318004695/formfour.xml","form_type":"4"}},{"id":3892288,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2018-06-15T23:32:06.000Z","date":"2018-06-14","kind":"tax_withholding","acquired":false,"shares":2856,"price":8.3,"value":23704.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the closing price of the Company's common shares in U.S. dollars on June 13, 2018, which was converted to a Canadian dollar amount for purposes of net settlement calculations."}],"balance_after":17402,"source":{"system":"sec-edgar","filing":"0001171843-18-004695","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000117184318004695/formfour.xml","form_type":"4"}},{"id":3892287,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2018-06-15T23:32:06.000Z","date":"2018-06-14","kind":"exercise","acquired":true,"shares":8230,"price":3.7,"value":30451.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The exercise price was converted to U.S. dollars from $3.74 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the day of exercise."}],"balance_after":20258,"source":{"system":"sec-edgar","filing":"0001171843-18-004695","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000117184318004695/formfour.xml","form_type":"4"}},{"id":3904954,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-05T20:41:00.000Z","date":"2018-06-04","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the total shares subject to the Option shall vest on the one year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the two year anniversary of the grant date, and the balance of the total shares subject to the Option shall vest on the three year anniversary of the grant date."}],"balance_after":15000,"derivative":{"exercise_price":6.2,"expiration_date":"2028-06-03","underlying":"Common Shares","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001171843-18-004458","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000117184318004458/form4.xml","form_type":"4"}},{"id":4235176,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-08-14T22:07:48.000Z","date":"2017-08-10","kind":"purchase","acquired":true,"shares":7500,"price":2.7781,"value":20835.75,"ownership":{"direct":false,"nature":"See Note"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares purchased. These shares were purchased in multiple transactions at prices ranging from $2.7769 to $2.80, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"By Gary & Karen Barbara Patou TTEE Patou Family Trust FBO Gary Patou Karen Barbara Patou"}],"balance_after":12500,"source":{"system":"sec-edgar","filing":"0001171843-17-005072","document":"f4_patou081417.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000117184317005072/f4_patou081417.xml","form_type":"4"}},{"id":4237668,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-08-10T23:58:13.000Z","date":"2017-08-08","kind":"purchase","acquired":true,"shares":5000,"price":3.0005,"value":15002.5,"ownership":{"direct":false,"nature":"See note"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By Gary & Karen Barbara Patou TTEE Patou Family Trust FBO Gary Patou Karen Barbara Patou"}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001171843-17-004960","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000117184317004960/formfour.xml","form_type":"4"}},{"id":4295546,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-02T21:00:39.000Z","date":"2017-06-01","kind":"grant","acquired":true,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the total shares subject to the Option shall vest on the one year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the two year anniversary of the grant date, and the balance of the total shares subject to the Option shall vest on the three year anniversary of the grant date."}],"balance_after":3500,"derivative":{"exercise_price":3.85,"expiration_date":"2027-05-31","underlying":"Common Shares","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0001171843-17-003445","document":"formfour.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000117184317003445/formfour.xml","form_type":"4"}},{"id":4528473,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2016-12-08T21:52:27.000Z","date":"2016-12-06","kind":"exercise","acquired":false,"shares":12345,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted to U.S. dollars from $3.74 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the day of exercise."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option fully vested on December 31, 2009."}],"balance_after":0,"derivative":{"exercise_price":3.21,"expiration_date":"2016-12-31","underlying":"Common Shares","underlying_shares":12345},"source":{"system":"sec-edgar","filing":"0001171843-16-013554","document":"form4patou.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000117184316013554/form4patou.xml","form_type":"4"}},{"id":4528472,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2016-12-08T21:52:27.000Z","date":"2016-12-06","kind":"tax_withholding","acquired":false,"shares":4403,"price":7.9,"value":34783.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Pursuant to the terms of a Lock-up Agreement executed by the Reporting Person in favor of the underwriters of the Company's Public Offering in September 2016 (the \"Lock-up\"), the Company withheld the number of shares set forth above pursuant to a net settlement permitted under the terms of the Lock-up.  No shares were sold by the Reporting Person in connection with the exercise and the common shares issued as a result of the exercise are subject to the terms of the Lock-up."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the closing price of the Company's common shares in U.S. dollars on December 5, 2016, which was converted to a Canadian dollar amount for purposes of net settlement calculations."}],"balance_after":12028,"source":{"system":"sec-edgar","filing":"0001171843-16-013554","document":"form4patou.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000117184316013554/form4patou.xml","form_type":"4"}},{"id":4528471,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":40437,"kind":"person","name":"PATOU GARY","position":1,"cik":"0001283535","reported_name":"PATOU GARY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2016-12-08T21:52:27.000Z","date":"2016-12-06","kind":"exercise","acquired":true,"shares":12345,"price":3.21,"value":39627.45,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The exercise price was converted to U.S. dollars from $3.74 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the day of exercise."}],"balance_after":16431,"source":{"system":"sec-edgar","filing":"0001171843-16-013554","document":"form4patou.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1283535/000117184316013554/form4patou.xml","form_type":"4"}}]}